91Ó°ÊÓ

An experiment was carried out to assess the effect of Sweet Talk, a text messaging support system for patients with diabetes ("A Randomized Controlled Trial of Sweet Talk," Diabetic Medicine \([2 \mathrm{OO} 6]: 1332-1338) .\) Participants in the experiment were 92 patients, age 8 to \(18,\) with type I diabetes who had been on conventional insulin treatment for at least one year. Participants were assigned at random to one of three experimental groups: Group 1: continued conventional insulin therapy Group 2: continued conventional insulin therapy with Sweet Talk support Group 3: followed a new intensive insulin therapy with Sweet Talk support One response variable was a measure of glucose concentration in the blood. There was no significant difference in glucose concentration between groups 1 and \(2,\) but group 3 showed a significant improvement in this measure compared to groups 1 and 2 . a. Explain why it is not reasonable to attribute the observed improvement in group 3 compared to group 1 to the use of Sweet Talk, even though subjects were randomly assigned to the three experimental groups. b. How would you modify this experiment so that you could tell if improvement in glucose concentration was attributable to the intensive insulin therapy, the use of Sweet Talk, or a combination of the two? c. Draw a diagram showing the structure of the modified experiment from Part (b).

Step by step solution

01

Understanding the Experiment

The experiment involved 92 patients with type I diabetes divided into three groups. Group 1: Conventional insulin therapy Group 2: Conventional insulin therapy with Sweet Talk support Group 3: Intensive insulin therapy with Sweet Talk support. A key finding is that there wasn't a significant difference in glucose concentration between group 1 and group 2 but a significant improvement in group 3.

02

Answer Part a: Questioning the Attribution of Outcomes

It's not reasonable to attribute the observed improvement in group 3 compared to group 1 to the use of Sweet Talk because both group 2 and group 3 involved Sweet Talk but only group 3 showed significant improvement. The only difference between group 2 and group 3 is the type of insulin therapy. Therefore, the improvement in group 3 can be attributed more to the intensive insulin therapy rather than the use of Sweet Talk.

03

Answer Part b: Modifying the Experiment

To better attribute the improvement in glucose concentration, a fourth group can be introduced in the experiment. This group would only follow the new intensive insulin therapy without Sweet Talk support. This way, the effects of the intensive insulin therapy and Sweet Talk support can be isolated and compared.

04

Answer Part c: Diagram of Modified Experiment

In the newer experimental structure, there would be: Group 1: Conventional insulin therapy Group 2: Conventional insulin therapy with Sweet Talk support Group 3: Intensive insulin therapy with Sweet Talk support Group 4: Intensive insulin therapy without Sweet Talk support. This way, we can compare outcomes across these groups to attribute results to individual factors or a combination.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Randomized Controlled Trial

A Randomized Controlled Trial (RCT) is a powerful method used to determine the effectiveness of interventions by randomly assigning participants to different groups.
This strategy helps minimize biases and confounding factors, ensuring that the experiment's results are reliable and accurate. Random assignment in an RCT means that each participant has an equal chance of being placed in any group, which helps balance out unknown variables.
In the context of the Sweet Talk study, 92 young patients with Type I Diabetes were randomly assigned to one of three treatment groups to identify the impacts of insulin therapies and supportive text messaging on glucose concentration.
By using randomness, researchers aim to ensure that differences in outcomes, such as changes in glucose concentration, can be more confidently attributed to the treatment itself and not other external factors.

Glucose Concentration

Glucose concentration refers to the amount of glucose present in the blood, which is critical for managing diabetes.
In individuals with Type I Diabetes, maintaining appropriate glucose levels is essential as it helps prevent complications that can arise from both low and high blood sugar.
Within the Sweet Talk study, the glucose concentration served as a key response variable to assess the effectiveness of the different insulin therapies and the support system.
Understanding and managing glucose concentration helps in evaluating how different treatments affect blood sugar levels, thereby guiding both patients and healthcare providers in making informed decisions.

Insulin Therapy

Insulin therapy is a cornerstone in the management of Type I Diabetes, as it replaces the insulin that the pancreas fails to produce.
Different types of insulin therapies are tailored to control blood sugar levels effectively throughout the day.
In the experiment, the conventional insulin therapy was compared to a new intensive insulin regimen. Intensive insulin therapy generally involves more frequent administration of insulin and closer monitoring of blood glucose to maintain tighter control.
Group 3, which received intensive insulin therapy alongside Sweet Talk support, displayed significant improvement in glucose concentration, suggesting that intensified insulin management may offer better blood sugar control.

Type I Diabetes

Type I Diabetes is a chronic condition characterized by the pancreas's inability to produce insulin, leading to elevated blood glucose levels.
It typically manifests in childhood or adolescence, which demands lifelong management to prevent complications.
In the Sweet Talk study, the young participants all had Type I Diabetes, making it crucial to evaluate effective strategies for regulating blood sugar levels.
Understanding Type I Diabetes involves not only knowing about insulin and glucagon but also employing cutting-edge technologies and lifestyle management tools, such as the Sweet Talk support system, to improve patient outcomes.